Nadine Paiement - Intelgenx Technologs Vice President - Research & Development

IGXT Stock

USD 0.17 0.00 0.00%

President

Ms. Nadine Paiement is Vice President Research Development of the Company. She has over 10 years of experience in pharmaceutical research and development. She was with IntelGenx since June of 2005, where she grew into different positions including her most recent position as Senior Director, Research and Development. Prior to joining IntelGenx, from 1999 to 2005 Ms. Paiement worked as Formulation Scientist for Smartrix Technologies. Nadine Paiement holds a M.Sc. degree in Polymer Chemistry from Sherbrooke University, Montreal, Quebec and is coinventor of IntelGenx TriLayer technology. since 2016.

Age	46
Tenure	8 years
Phone	514 331 7440
Web	https://www.intelgenx.com

Paiement was with IntelGenx since 2005, where she grew into different positions including her most recent position as senior director, research and development. She is the coinventor of IntelGenx three platform technologies. As vicepresident of research and development she is responsible for managing the company research and development efforts necessary to meet the corporate goals. She is also responsible for advancing the company current and emerging product pipeline through early to latestage development and regulatory filing. Her strong background in the pharmaceutical industry encompasses all areas from the laboratory level through to manufacturing scaleup, and during her more than 14 years experience she has developed a highly creative approach to the development of new methods and resolving technical issues. She is the coinventor of four patents and multiple pending applications, and has published articles in various recognized journals.

Intelgenx Technologs Management Efficiency

The company has return on total asset (ROA) of (0.367) % which means that it has lost $0.367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.2896) %, meaning that it created substantial loss on money invested by shareholders. Intelgenx Technologs' management efficiency ratios could be used to measure how well Intelgenx Technologs manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Intelgenx Technologs to Peers

Predict price of Intelgenx Technologs

Intelgenx Technologs currently holds 6.21 M in liabilities with Debt to Equity (D/E) ratio of 6.42, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intelgenx Technologs has a current ratio of 3.55, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Intelgenx Technologs until it has trouble settling it off, either with new capital or with free cash flow. So, Intelgenx Technologs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intelgenx Technologs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intelgenx to invest in growth at high rates of return. When we think about Intelgenx Technologs' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records			PRESIDENT Age
	Lei Fang	Fennec Pharmaceuticals	N/A
	Steven Perrin	Eledon Pharmaceuticals	58
	Kelly Carranza	Acumen Pharmaceuticals	N/A
	David JD	Connect Biopharma Holdings	50
	David Szekeres	Connect Biopharma Holdings	50
	James Doherty	Acumen Pharmaceuticals	56
	Wubin MBA	Connect Biopharma Holdings	59
	CPA Esq	Acurx Pharmaceuticals LLC	57

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange. Intelgenx Technologs [IGXT] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

	Return On Equity	-5.29
	Return On Asset	-0.37

Intelgenx Technologs Leadership Team

Elected by the shareholders, the Intelgenx Technologs' board of directors comprises two types of representatives: Intelgenx Technologs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelgenx. The board's role is to monitor Intelgenx Technologs' management team and ensure that shareholders' interests are well served. Intelgenx Technologs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelgenx Technologs' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Stephen Kilmer, Investor Officer
	JD LLB, VP Counsel
	Ingrid Zerbe, Director - Finance and Administration, Corporate Secretary
	Nadine Paiement, Vice President - Research & Development
	Horst Zerbe, Founder, Chairman, CEO and Pres

Intelgenx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Intelgenx Technologs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-5.29
	Return On Asset	-0.37
	Operating Margin	(7.39) %
	Current Valuation	30.97 M
	Shares Outstanding	174.65 M
	Shares Owned By Insiders	22.64 %
	Price To Earning	(55.38) X
	Price To Book	11.54 X
	Price To Sales	19.11 X
	Revenue	1.53 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelgenx Pink Sheet Analysis

When running Intelgenx Technologs' price analysis, check to measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC